Gary S Hoffman Selected Research

Granulomatosis with Polyangiitis (Wegener's Granulomatosis)

1/2019	Face Transplantation for Granulomatosis With Polyangiitis (Wegener Granulomatosis): Technical Considerations, Immunological Aspects, and 3-Year Posttransplant Outcome.
12/2018	Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis.
1/2018	Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
1/2017	The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
12/2016	Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
6/2016	Malignant Pyoderma Associated with Granulomatosis with Polyangiitis (Wegener Granulomatosis) as a Unique Indication for Facial Vascularized Composite Allotransplantation: Part I.
6/2016	Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
8/2015	Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis.
5/2015	Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis.
4/2015	Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gary S Hoffman Research Topics

Disease

41	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2019 - 05/2003
26	Vasculitis (Vasculitides) 02/2023 - 09/2007
22	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2022 - 05/2007
9	Takayasu Arteritis (Arteritis, Takayasu's) 01/2017 - 06/2002
8	Microscopic Polyangiitis 01/2018 - 04/2003
7	Giant Cell Arteritis (Horton Disease) 01/2017 - 05/2002
6	Inflammation (Inflammations) 02/2022 - 07/2004
4	Hemorrhage 11/2019 - 10/2006
3	Churg-Strauss Syndrome (Allergic Angiitis) 03/2017 - 04/2003
3	Glomerulonephritis 01/2017 - 01/2012
3	Neoplasms (Cancer) 08/2011 - 05/2006
3	Pathologic Constriction (Stenosis) 09/2010 - 05/2003
2	Aortitis 01/2019 - 07/2015
2	Granuloma 12/2018 - 07/2004
2	Hematuria 01/2018 - 11/2009
2	Proteinuria 01/2018 - 11/2009
2	Infections 07/2014 - 05/2007
2	Lung Diseases (Lung Disease) 02/2014 - 04/2003
2	Stroke (Strokes) 04/2011 - 10/2006
2	Body Weight (Weight, Body) 07/2010 - 05/2007
1	Venous Thromboembolism 11/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Renal Insufficiency (Renal Failure) 01/2018
1	Infertility (Sterility) 06/2016
1	Pyoderma 06/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Aneurysm (Aneurysms) 07/2015
1	Sepsis (Septicemia) 07/2015
1	Thoracic Aortic Aneurysm 07/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2015
1	Disease Susceptibility (Diathesis) 04/2015
1	Cholecystitis 11/2014
1	Gallstones (Gallstone) 11/2014
1	Critical Illness (Critically Ill) 01/2012
1	Vascular System Injuries 12/2011
1	Hypertension (High Blood Pressure) 04/2011
1	Myocardial Infarction 04/2011
1	Conjunctivitis 09/2010
1	Corneal Ulcer 09/2010
1	Uveitis 09/2010
1	Scleritis (Episcleritis) 09/2010
1	Sneddon Syndrome (Syndrome, Sneddon) 04/2010
1	Cicatrix (Scar) 01/2010

Drug/Important Bio-Agent (IBA)

33	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2023 - 04/2003
17	Rituximab (Mabthera)FDA Link 11/2019 - 07/2010
14	Biomarkers (Surrogate Marker)IBA 02/2023 - 06/2011
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 02/2006
12	Etanercept (Enbrel)FDA Link 12/2016 - 07/2005
10	Myeloblastin (Proteinase 3)IBA 02/2023 - 04/2003
7	Peroxidase (Myeloperoxidase)IBA 02/2023 - 04/2003
6	Methotrexate (Mexate)FDA LinkGeneric 03/2014 - 05/2002
5	Azathioprine (Imuran)FDA LinkGeneric 01/2017 - 01/2005
5	GlucocorticoidsIBA 01/2017 - 03/2007
4	AntibodiesIBA 03/2017 - 05/2007
4	Prednisone (Sone)FDA LinkGeneric 01/2017 - 07/2014
3	Abatacept (Orencia)FDA Link 01/2017 - 07/2014
3	AntigensIBA 07/2015 - 04/2003
3	CreatinineIBA 04/2015 - 12/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2011 - 07/2004
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2005 - 05/2002
2	CytokinesIBA 01/2018 - 08/2004
2	Immunoglobulin A (IgA)IBA 03/2017 - 12/2011
2	Immunoglobulin G (IgG)IBA 03/2017 - 12/2011
2	EnzymesIBA 01/2017 - 11/2007
2	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 05/2015
2	Proteins (Proteins, Gene)FDA Link 07/2015 - 08/2013
2	Cytotoxins (Cytolysins)IBA 12/2011 - 08/2011
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	PorphyrinsIBA 01/2019
1	ChemokinesIBA 12/2018
1	Macrophage Migration-Inhibitory FactorsIBA 12/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2017
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2017
1	AutoantibodiesIBA 01/2017
1	Immunoglobulin E (IgE)IBA 08/2015
1	Antinuclear AntibodiesIBA 07/2015
1	AutoantigensIBA 07/2015
1	Interleukin-6 (Interleukin 6)IBA 05/2015
1	Amino Acids FDA Link 04/2015
1	N-phthaloylglutamic acidIBA 02/2014
1	HLA-DPB1 antigen (HLA DPB1)IBA 09/2013
1	HLA-B Antigens (HLA-B)IBA 08/2013
1	Blood Proteins (Serum Proteins)IBA 08/2013
1	Angiopoietin-2IBA 01/2012
1	Fc Receptors (Fc Receptor)IBA 12/2011
1	Retinaldehyde (Retinal)IBA 09/2010
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 04/2010
1	chitotriosidaseIBA 03/2010

Therapy/Procedure

20	Therapeutics 01/2018 - 07/2004
8	Remission Induction 02/2023 - 05/2006
1	Facial Transplantation 01/2019
1	Homologous Transplantation 01/2019
1	Vascularized Composite Allotransplantation 06/2016
1	Cholecystectomy 11/2014
1	Duration of Therapy 03/2014
1	Biological Therapy 01/2014
1	Aftercare (After-Treatment) 12/2011
1	Percutaneous Coronary Intervention 04/2011
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2011